Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.

acute infarct
avid
peripheral neuropathy
localized disease
phenytoin
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Study objective is to compare the efficacy and safety of camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.

substance abuse
monoclonal antibodies
resectable osteosarcoma
hepatitis c
psychotropic
  • 0 views
  • 19 Feb, 2024
  • 1 location
ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities

In some sites they will consider the non-administration of MTP-PE or the non-administration of high doses of ifosfamide. And, in some hospitals, they will consider administering MTP-PE to all patients.

adjuvant therapy
tumor necrosis
metastasis
ifosfamide
localized disease
  • 0 views
  • 19 Feb, 2024
  • 17 locations